{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
etoposide phosphate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
BLA125752
(2022)
Source URL:
First approved in 2022
Source:
BLA125752
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
First approved in 2007
Source:
21 CFR 352
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2016)
Source:
NDA208114
(2016)
Source URL:
First approved in 2016
Source:
NDA208114
Source URL:
Class:
POLYMER
Status:
US Approved Rx
(2023)
Source:
ANDA206100
(2023)
Source URL:
First approved in 1998
Source:
RENAGEL by GENZYME
Source URL:
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
Investigational
Source:
USAN:Omafilcon A [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
Ann Oncol. Mar 2008;19(3):520-6.: Phase 3 Human clinical trial Completed Stomach Neoplasms/mortality/surgery
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT00268593: Phase 2 Interventional Completed Prostate Cancer
(2005)
Source URL:
Class:
POLYMER
Status:
Other
Class:
POLYMER
